| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |